title: BD BodyGuard™ Pumps – RS-232 Interface Vulnerability
description: The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump.
problem types: CWE-1299 Missing Protection Mechanism for Alternate Hardware Interface
affected:
{
defaultStatus: unaffected
product: BodyGuard™ Pump
vendor: Becton, Dickinson and Company (BD)
versions:
status: affected, version: BD BodyGuard™
status: affected, version: CME BodyGuard™ 323 (2nd Edition)
status: affected, version: CME BodyGuard™ 323 Color Vision (2nd Edition)
status: affected, version: CME BodyGuard™ 323 Color Vision (3rd Edition)
status: affected, version: CME BodyGuard™ Twins (2nd Edition)
}
metrics:
cvssV3_1: [
attackComplexity: HIGH
attackVector: PHYSICAL
availabilityImpact: HIGH
baseScore: 5.3
baseSeverity: MEDIUM
confidentialityImpact: LOW
integrityImpact: LOW
privilegesRequired: NONE
scope: UNCHANGED
userInteraction: NONE
vectorString: CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
version: 3.1
]
format: CVSS
scenarios: GENERAL
workarounds: BD recommends the following mitigations and compensating controls to reduce risk associated with this
vulnerability:
• Ensure physical access controls are in place and only authorized end-users have access to
BD BodyGuard™ pumps.
• Ensure that only BD-approved equipment is connected to the RS-232 interface of the affected pumps.
• Ensure that no equipment is connected to the RS-232 interface when the affected pumps are delivering
infusions.
• Protect connected computer systems with BodyComm™ software with standard security measures.